European Journal of Obstetrics and Gynecology and Reproductive Biology, 256, 179-183. Elsevier Ireland Ltd Middelkoop, M A, Harmsen, M J, Manyonda, I, Mara, M, Ruuskanen, A, Daniels, J, Mol, B W J, Moss, J, Hehenkamp, W J K & Wu, O 2021, ' Uterine artery embolization versus surgical treatment in patients with symptomatic uterine fibroids : Protocol for a systematic review and meta-analysis of individual participant data ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 256, pp. 179-183 . https://doi.org/10.1016/j.ejogrb.2020.11.027
European Journal of Obstetrics and Gynecology and Reproductive Biology, 252, 256-264. Elsevier Ireland Ltd De Milliano, I, Middelkoop, M A, Huirne, J A F, Kwee, J, Geomini, P M A J, Schoot, B C, Van Baal, M, Bosmans, J E & Hehenkamp, W J K 2020, ' Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Long term results of a double-blind randomized controlled trial ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 252, pp. 256-264 . https://doi.org/10.1016/j.ejogrb.2020.06.035 De Milliano, I, Middelkoop, M A, Huirne, J A F, Kwee, J, Geomini, P M A J, Schoot, B C, Van Baal, M, Bosmans, J E & Hehenkamp, W J K 2020, ' Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial) : Long term results of a double-blind randomized controlled trial ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 252, pp. 256-264 . https://doi.org/10.1016/j.ejogrb.2020.06.035
Middelkoop, M-A, Bet, P M, Drenth, J P H, Huirne, J A F & Hehenkamp, W J K 2021, ' Risk–efficacy balance of ulipristal acetate compared to surgical alternatives : How to value safety in a new drug? ', British Journal of Clinical Pharmacology, vol. 87, no. 7, pp. 2685-2697 . https://doi.org/10.1111/bcp.14708, https://doi.org/10.1111/bcp.14708
American journal of obstetrics and gynecology, 219(4), 424-425. Mosby Inc. Middelkoop, M-A & Huirne, J A F 2018, ' Re: The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids ', American Journal of Obstetrics and Gynecology, vol. 219, no. 4, pp. 424-425 . https://doi.org/10.1016/j.ajog.2018.05.014 American Journal of Obstetrics and Gynecology, 219(4), 424-425. Mosby Inc.